Our Research

At the Jacobs School, we advance research and discovery to improve health for all. Our multidisciplinary research advances basic and clinical science; we translate those discoveries into clinical care that improves health in our communities. With our eyes on the future, we are increasing the number of students and trainees who pursue careers in research, biomedical science and academic medicine.

NEJM Study: For Chronic Subdural Hematomas, Blocking the Artery Supplying the Brain Covering Reduced Re-Operations Threefold
11/20/24

A dramatic reduction in repeat operations in patients surgically treated for chronic subdural hematoma was achieved when the artery supplying the brain covering was blocked, according to results published in the New England Journal of Medicine. 

previous next
Students Partake in Innovative Research on Dysautonomia
12/18/23

A number of medical students are gaining valuable clinical research experience studying autonomic disorders under the direction of Svetlana Blitshteyn, MD, a clinical associate professor of neurology at the Jacobs School of Medicine and Biomedical Sciences.

previous next
Study Results of First Permanently Implanted Brain-Computer Interface Will be Presented at CNS
9/26/24

Elad I. Levy, MD, MBA, will present results of the clinical trial that assessed the safety of Synchron’s endovascular brain-computer interface in people with severe paralysis at the Congress of Neurological Surgeons.

previous next
UB-Founded Company Uses AI to Assist Surgeons Treating Brain Aneurysms in Real Time
12/18/23

QAS.AI awarded $1 million National Science Foundation grant for clinical evaluation in Buffalo and Florida.

previous next

Learn More About Our Research

Our Experts in the News

Recent Publications

See more

Recent Research Funding

  • Molecular Physiology of NMDA Receptors. Gabriela Popescu (Principal Investigator). NINDS. $4,200,000. 5/1/2023-4/1/2031.
  • NIH NCATS ASPIRE Design Award. Ram Samudrala (Principal Investigator). NIH. $100,000. 9/1/2019-1/1/2030.
  • NIH NCATS ASPIRE Reduction-to-Practice Award. Ram Samudrala (Co-Principal Investigator). NCATS. $1,220,000. 8/1/2021-1/1/2030.
  • Selective galactosylceramidase ablation to study the pathogenesis of Krabbe leukodystrophy. Daesung Shin (Principal Investigator). NIH. $2,013,407. 12/1/2024-12/1/2029.
  • Overdose Data to Action in States (OD2A): Bio surveillance. Brian Clemency (Principal Investigator). Centers for Disease Control and Prevention (Subaward from NYS Department of Health/Health Research Inc.). $250,000. 9/1/2024-8/1/2029.
See more